| 1 | Blinatumomab | [1] Blinatumomab Blinatumomab (Blinatumomab) | [1] Blinatumomab
Blinatumomab
(Blinatumomab) 💬
| [4] CD19 CD19, CD3D, CD3E, CD3G 💬
| [13] B cell receptor signaling pathway B cell receptor signaling pathway, Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [4] 11 11, 46, 49, 222 💬
|
| 2 | Blinatumomab 9ug | [1] Blinatumomab Blinatumomab (Blinatumomab) | [1] Blinatumomab
Blinatumomab
(Blinatumomab) 💬
| [4] CD19 CD19, CD3D, CD3E, CD3G 💬
| [13] B cell receptor signaling pathway B cell receptor signaling pathway, Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [1] 49 49 💬
|
| 3 | Blinatumomab Treatment | [1] Blinatumomab Blinatumomab (Blinatumomab) | [1] Blinatumomab
Blinatumomab
(Blinatumomab) 💬
| [4] CD19 CD19, CD3D, CD3E, CD3G 💬
| [13] B cell receptor signaling pathway B cell receptor signaling pathway, Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [1] 222 222 💬
|